Revolutionizing Diagnostics: Brand CBC Analyzer Solutions by Ozelle

Introduction: The Evolution of CBC Testing

Complete blood count (CBC) analysis stands as one of the most critical diagnostic tools in modern medicine and veterinary care. A brand CBC analyzer represents the pinnacle of diagnostic excellence, combining precision engineering with advanced artificial intelligence to deliver rapid, accurate results. Ozelle has established itself as a global leader in CBC analyzer technology, offering innovative solutions that redefine diagnostic capabilities across healthcare facilities, laboratories, and veterinary clinics worldwide.

Understanding CBC Analyzers: Beyond Traditional Blood Testing

A CBC analyzer processes blood samples to measure multiple parameters including red blood cells (RBC), white blood cells (WBC), hemoglobin (HGB), hematocrit (HCT), and platelets (PLT). Traditional methods relied on basic counting techniques, but modern brand CBC analyzers incorporate sophisticated technology to provide comprehensive cell morphology analysis, abnormal cell detection, and multi-parameter evaluation.

The distinction between standard and premium CBC analyzers lies in their analytical capabilities. Leading brands like Ozelle have developed analyzers capable of identifying not just standard cell types but also abnormal formations such as nucleated segmented cells (NST), immature neutrophils (NSG), and reticulocytes (RET)—parameters that provide deeper clinical insights.

Ozelle’s CBC Analyzer Portfolio: Advanced Technology for Every Setting

Ozelle offers a comprehensive range of brand CBC analyzers designed to meet diverse clinical needs:

EHBT-75: Intelligent 7-Diff Cell Morphology Analyzer

The EHBT-75 represents Ozelle’s flagship offering for advanced diagnostics. This analyzer delivers:

• AI-Powered Precision: Deep learning algorithms trained on over 40 million samples enable exceptional accuracy in cell identification and classification
• Comprehensive Parameter Analysis: 37 parameters covering standard CBC metrics plus advanced abnormal cell detection (NST, NSG, NSH, NLR, PLR, ALY, PAg, RET)
• Rapid Result Delivery: AI-driven morphological reports generated within 6 minutes
• Maintenance-Free Operation: Single-use test kits eliminate the need for complex maintenance and cross-contamination risks
• Liquid-Based Staining: Enhanced color dimension and image quality for superior cellular visualization
• Flexible Sampling: Accommodates both capillary (30-60 μL) and venous blood samples

EHBT-50: Multi-Functional Analyzer for Comprehensive Diagnostics

Beyond CBC capabilities, the EHBT-50 integrates multiple testing modalities:

• All-In-One Integration: Combines 7-diff hematology, immunoassay, biochemistry, urine, and fecal analysis in a single device
• Advanced Cell Morphology: Identifies 37 parameters including abnormal cell classifications
• Expanded Test Range: Covers bone metabolism, diabetes markers, kidney function, thyroid assessment, cardiac markers, inflammatory markers, and thrombus detection
• High Throughput: Processes 10 samples per hour with 10.1-inch touch screen interface
• Lab-Grade Performance: Exceptional linearity and precision comparable to international reference standards

EHBT-25: Compact 3-Diff Analyzer for Primary Diagnostics

For facilities requiring economical, space-efficient solutions:

• Basic CBC Coverage: 3-diff hematology with essential parameters (WBC, GRAN, LYMPH, MID, HGB, RBC, HCT, MCV, MCH, MCHC, PLT)
• Affordable and Compact: Designed for primary healthcare, mobile units, and ambulances
• Maintenance-Free Design: Individual test kits with room temperature storage
• High Throughput: 12 samples per hour throughput for busy clinics

Why Choose a Brand CBC Analyzer from Ozelle?

Technological Excellence

Ozelle’s CBC analyzers leverage proprietary cell morphology technology combined with advanced machine vision and AI algorithms. The company’s innovations have been recognized at the 2022 World Artificial Intelligence Conference (WAIC), validating the precision and reliability of their diagnostic approach.

Global Proven Track Record

With 50,000 units installed worldwide and over 40 million samples processed, Ozelle demonstrates unparalleled clinical validation. This extensive operational history ensures that their CBC analyzers have been tested and refined in real-world healthcare settings globally.

Regulatory Compliance and Certification

All Ozelle CBC analyzers meet rigorous international standards:

• CE Certification: European Union regulatory approval
• FDA Recognition: U.S. medical device authorization
• ISO 13485:2016 Compliance: Medical device quality management standards
• CQC Certification: Third-party quality assurance

Comprehensive Parameter Analysis

Premium brand CBC analyzers from Ozelle don’t simply count cells—they analyze cell morphology with exceptional detail. Modern analyzers identify abnormal formations that traditional impedance methods might miss, providing clinicians with richer diagnostic information for more informed decision-making.

Key Performance Metrics: What Sets Brand CBC Analyzers Apart

When evaluating CBC analyzer options, laboratory professionals should consider these critical performance indicators:

Performance Metric	Ozelle CBC Analyzers	Standard Value
AI Algorithm Training Data	40+ million samples​	Highly developed models
Cell Morphology Parameters	7-diff to 37+ parameters​	Advanced classification
Result Turnaround Time	6-10 minutes​	Rapid diagnostics
Sample Throughput	8-12 samples/hour​	Efficient workflow
Maintenance Requirement	Maintenance-free with individual kits​	Zero downtime
Precision (Coefficient of Variation)	2.5-6.0% across parameters​	Laboratory-grade accuracy
Linearity (R² Value)	0.98-0.99+ across parameters​	Exceptional consistency

Advanced Features of Ozelle’s Brand CBC Analyzers

AI-Driven Cell Recognition

Ozelle’s proprietary algorithms utilize deep learning trained on over 40 million samples to recognize and classify blood cells with precision eyes featuring Swiss Optic customized lenses (4M resolution, 50 fps). This technological advancement enables detection of rare and abnormal cells that might be missed by traditional analyzers.

Comprehensive Abnormal Cell Detection

Modern diagnostic protocols require more than basic CBC counts. Ozelle’s brand analyzers identify:

• Nucleated segmented cells (NST)
• Neutrophil granules (NSG)
• Neutrophil hypersegmentation (NSH)
• Reticulocytes (RET)
• Abnormal lymphocytes (ALY)
• Platelet aggregates (PAg)
• Atypical blood cell morphologies

Multi-Application Flexibility

Ozelle CBC analyzers serve diverse healthcare environments:

• Hospital laboratories and diagnostic centers
• Primary care clinics and urgent care facilities
• Veterinary clinics and animal hospitals
• Mobile diagnostic units and ambulances
• Emergency departments and trauma centers

Implementation and Integration

Leading brand CBC analyzers from Ozelle integrate seamlessly into existing laboratory information systems (LIS) through multiple connectivity options:

• LIS/HIS Integration: Direct laboratory system connectivity for automated data management
• Multiple Communication Ports: USB, LAN (RJ45), WiFi (IEEE 802.11 bgn), and Bluetooth connectivity
• Flexible Output: Built-in thermal printers with external printer options for comprehensive documentation
• Data Security: Reliable data transfer with quality assurance protocols

The Future of CBC Analysis: Ozelle’s Vision

The evolution of CBC analyzer technology reflects the broader transformation of diagnostic medicine. As healthcare systems demand faster, more accurate, and more comprehensive diagnostics, brand CBC analyzers continue advancing through:

• Enhanced AI algorithms trained on expanding sample databases
• Integration with immunoassay and biochemistry testing
• Development of species-specific analyzers for veterinary applications
• Improved accessibility for resource-limited healthcare settings

Ozelle continues investing in research and development, with over 500 patents and 60+ R&D staff across three innovation centers, ensuring that their CBC analyzers remain at the forefront of diagnostic technology.

Conclusion: Investing in Diagnostic Excellence

Choosing a brand CBC analyzer is a critical investment in laboratory capabilities and patient care quality. Ozelle’s portfolio of advanced CBC analyzers represents the convergence of cutting-edge technology, clinical validation, and practical design. Whether your facility requires a simple, compact 3-diff analyzer or a comprehensive multi-functional diagnostic platform, Ozelle provides proven solutions that enhance diagnostic accuracy, improve efficiency, and ultimately better serve patients and pets.

With proven global performance, regulatory compliance, and continuous innovation, Ozelle brand CBC analyzers stand as the benchmark for diagnostic excellence in modern healthcare and veterinary medicine.

Transform your laboratory. Elevate your diagnostics. Choose Ozelle.